ProShare Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,031
| Closed | -$1.04M | – | 2443 |
|
|
2021
Q1 | $1.04M | Buy |
13,031
+1,683
| +15% | +$131K | ﹤0.01% | 960 |
|
|
2020
Q4 | $895K | Buy |
11,348
+4,166
| +58% | +$244K | ﹤0.01% | 936 |
|
|
2020
Q3 | $316K | Sell |
7,182
-165,394
| -96% | -$8.15M | ﹤0.01% | 1146 |
|
|
2020
Q2 | $7.63M | Buy |
+172,576
| New | +$6.44M | 0.04% | 305 |
|
|
2020
Q1 | – | Sell |
-4,070
| Closed | -$289K | – | 1725 |
|
|
2019
Q4 | $289K | Buy |
4,070
+441
| +12% | +$32K | ﹤0.01% | 1355 |
|
|
2019
Q3 | $271K | Sell |
3,629
-141
| -4% | -$12K | ﹤0.01% | 1277 |
|
|
2019
Q2 | $304K | Sell |
3,770
-686
| -15% | -$48.2K | ﹤0.01% | 1233 |
|
|
2019
Q1 | $298K | Buy |
4,456
+982
| +28% | +$74.4K | ﹤0.01% | 1262 |
|
|
2018
Q4 | $259K | Sell |
3,474
-804
| -19% | -$66.4K | ﹤0.01% | 1232 |
|
|
2018
Q3 | $394K | Buy |
4,278
+1,261
| +42% | +$120K | ﹤0.01% | 1212 |
|
|
2018
Q2 | $297K | Sell |
3,017
-4,629
| -61% | -$518K | ﹤0.01% | 1392 |
|
|
2018
Q1 | $852K | Buy |
7,646
+1,164
| +18% | +$130K | 0.01% | 890 |
|
|
2017
Q4 | $667K | Buy |
6,482
+3,291
| +103% | +$328K | ﹤0.01% | 996 |
|
|
2017
Q3 | $300K | Sell |
3,191
-563
| -15% | -$44.4K | ﹤0.01% | 1137 |
|
|
2017
Q2 | $292K | Sell |
3,754
-1,213
| -24% | -$91.1K | ﹤0.01% | 1183 |
|
|
2017
Q1 | $398K | Sell |
4,967
-1,595
| -24% | -$127K | ﹤0.01% | 1103 |
|
|
2016
Q4 | $517K | Buy |
6,562
+2,304
| +54% | +$179K | 0.01% | 1056 |
|
|
2016
Q3 | $332K | Sell |
4,258
-928
| -18% | -$67.3K | ﹤0.01% | 1113 |
|
|
2016
Q2 | $356K | Buy |
5,186
+160
| +3% | +$11K | ﹤0.01% | 1122 |
|
|
2016
Q1 | $359K | Sell |
5,026
-862
| -15% | -$54.1K | ﹤0.01% | 1136 |
|
|
2015
Q4 | $366K | Buy |
5,888
+1,946
| +49% | +$119K | ﹤0.01% | 1191 |
|
|
2015
Q3 | $224K | Sell |
3,942
-1,033
| -21% | -$54.7K | ﹤0.01% | 1267 |
|
|
2015
Q2 | $267K | Sell |
4,975
-2,504
| -33% | -$122K | ﹤0.01% | 1358 |
|
|
2015
Q1 | $355K | Sell |
7,479
-685
| -8% | -$30.3K | ﹤0.01% | 1372 |
|
|
2014
Q4 | $353K | Sell |
8,164
-6,164
| -43% | -$252K | ﹤0.01% | 1404 |
|
|
2014
Q3 | $493K | Sell |
14,328
-3,482
| -20% | -$123K | 0.01% | 1423 |
|
|
2014
Q2 | $652K | Sell |
17,810
-16,083
| -47% | -$546K | 0.01% | 1414 |
|
|
2014
Q1 | $1.14M | Buy |
+33,893
| New | +$1.12M | 0.01% | 1184 |
|
|
2013
Q4 | – | Sell |
-21,425
| Closed | -$682K | – | 2037 |
|
|
2013
Q3 | $682K | Sell |
21,425
-544
| -2% | -$14.5K | 0.02% | 1178 |
|
|
2013
Q2 | $496K | Buy |
+21,969
| New | +$476K | 0.01% | 1334 |
|
ProShare Advisors's CMD Position: Q2 2021 in Review
ProShare Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 13,031 shares — an estimated $1.04M sold.
ProShare Advisors first reported a position in CMD in Q2 2013 and held it in 30 quarters. The position peaked at $7.63M in Q2 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- ProShare Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- ProShare Advisors sold 13,031 Cantel Medical Corporation shares in Q2 2021, an estimated $1.04M.
- ProShare Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 30 quarters.
- ProShare Advisors's Cantel Medical Corporation position peaked at $7.63M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.